网站大量收购独家精品文档,联系QQ:2885784924
  1. 1、本文档共32页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Folie 1课件

Markus A. Weigand Department of Anesthesiology and Intensive Care Medicine Justus-Liebig-University Gie?en University Hospital Gie?en and Marburg Campus Gie?en * Antibiotic therapy of postoperative sepsis Hit hard and early Preferred antibiotics in severe sepsis Combination therapy Duration of antibiotic therapy Use of antibiotic diversity Conclusion Time is the critical factor ? Rivers et al. 2001 ?Early goal-dircted therapy“ ScVO2≥70% reduces mortality by 15% Kumar et al. 2006 Each hour of delay in antimicrobial administration was associated with a decrease in survival of 5 – 10% 6 h Kumar A et al. ICAAC, 2007: L-477 Critical role of adequate antibiotic therapy Hit hard and early Preferred antibiotics in severe sepsis Combination therapy Duration of antibiotic therapy Use of antibiotic diversity Conclusion Wong PF et al. Cochrane Database Syst Rev 2005 Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults No specific recommendations can be made No recent randomized trial for patients with severe sepsis Increasing Resistance for E. Coli G.-T.E.S.T. 1 vs. G.-T.E.S.T. 2; Kresken M et al. Chemother J 2008; 17(5):205-226; Resistant strains (%) Some guidelines recommend a combination therapy in severe sepsis Aminoglykosides, Chinolones, Tigecycline Only in patients with risk factors or with proven infections with MDR-bacteria guidelines uniformerly recommend combinations with Vancomycin, Linezolid, Daptomycin or Tigecycline Ceftazidime oder Cefepime + Metronidazole Piperacillin + Beta-Lactamase inhibitor Imipenem, Meropenem or Doripenem Recommended drug groups for empirical antibiotic treatment of severe nosocomial infections Hit hard and early Preferred antibiotics in severe sepsis Combination therapy Duration of antibiotic therapy Use of antibiotic diversity Conclusion Pat. without Shock Pat. with Shock Pseudomonas Bacteraemia There was no difference in 28 day mortality between the combination and monotherapy groups (CI: 0.78-1.42;

文档评论(0)

2017meng + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档